Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / General / General / January 2006

Tip: Looking for answers? Try searching our database.

Why No H5N1 Vaccine?

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
Jay Stallworth - 29 Dec 2005 23:56 GMT
Vaccine manufacturers have been making killed or attenuated vaccines from a
wide spectrum of flu viruses, and they've been doing it for 35 years or
more.  The technology is clearly completely mature, so it should be
straightforward  to simply apply their known techniques for manufacturing
flu vaccines to H5N1, thus defeating the pandemic problem before it
strikes.  Is there something unique about this particular strain that makes
it unsuitable for the application of existing techniques?
(PeteCresswell) - 30 Dec 2005 00:45 GMT
Per Jay Stallworth:
> Is there something unique about this particular strain that makes
>it unsuitable for the application of existing techniques?

Three problems that I have heard about:

1) Since the virus has not mutated to efficient human-to-human transmisability
(is that even a word..?.-) the exact strain upon which to base a vaccine is not
available.

2)  Flu vaccines have traditionally been manufactured by inoculating fertilized
chicken eggs, letting the stuff grow for awhile on the chick embryo, and then
harvesting the contents which is refined into vaccine.    H5N1, however, is so
lethal that it kills the chick embryo too soon - making the amount of vaccine
per egg much less or zero.

3) Vaccines are not money makers for the manufacturers.   Money losers, in fact
much of the time.   So far, our government has not seen fit to exercise any of
it's power to remedy this situation.  Consequently, vaccine production
facilities are substantially below what is actually needed and our surge
capacity is nil.
Signature

PeteCresswell

Howard McCollister - 30 Dec 2005 15:29 GMT
> Per Jay Stallworth:
>> Is there something unique about this particular strain that makes
[quoted text clipped - 25 lines]
> facilities are substantially below what is actually needed and our surge
> capacity is nil.

All good points, particularly #3. The return on vaccine manufacturing
doesn't justify doing it especially given the liability it exposes the
manufacturer to.

HMc
Jay Stallworth - 30 Dec 2005 19:10 GMT
"(PeteCresswell)" <x@y.Invalid> wrote in

> Per Jay Stallworth:
>> Is there something unique about this particular strain that makes
[quoted text clipped - 5 lines]
> transmisability (is that even a word..?.-) the exact strain upon which
> to base a vaccine is not available.

Isn't half a loaf better than none?

> 2)  Flu vaccines have traditionally been manufactured by inoculating
> fertilized chicken eggs, letting the stuff grow for awhile on the
> chick embryo, and then harvesting the contents which is refined into
> vaccine.    H5N1, however, is so lethal that it kills the chick embryo
> too soon - making the amount of vaccine per egg much less or zero.

Aren't the attenuated strains less lethal?

> 3) Vaccines are not money makers for the manufacturers.   Money
> losers, in fact much of the time.   So far, our government has not
> seen fit to exercise any of it's power to remedy this situation.
> Consequently, vaccine production facilities are substantially below
> what is actually needed and our surge capacity is nil.

Doesn't Dubya want to throw money at the problem?
Jim Chinnis - 30 Dec 2005 19:21 GMT
Jay Stallworth <jstall860@aol.com.nospam> wrote in part:

>Doesn't Dubya want to throw money at the problem?

He's already thrown it all away.
--
Jim Chinnis   Warrenton, Virginia, USA
Jay Stallworth - 31 Dec 2005 20:32 GMT
> Jay Stallworth <jstall860@aol.com.nospam> wrote in part:
>
>>Doesn't Dubya want to throw money at the problem?
>
> He's already thrown it all away.

As the Deficit Spender in Chief, his financial resources are limitless.
Gary - 02 Jan 2006 05:47 GMT
> Vaccine manufacturers have been making killed or attenuated vaccines from a
> wide spectrum of flu viruses, and they've been doing it for 35 years or
[quoted text clipped - 3 lines]
> strikes.  Is there something unique about this particular strain that makes
> it unsuitable for the application of existing techniques?

The human to human mutation AND the spread to a statistically significant
number of humans, not just isolated case(s), has to happen before you can
START, AND NOT BEFORE. Its a complete waste of time and money to start
before that event happens. After that, its going to be a race to the finish
and that could take months or even a year, or more.
(PeteCresswell) - 02 Jan 2006 15:44 GMT
Per Gary:
>has to happen before you can
>START, AND NOT BEFORE. Its a complete waste of time and money to start
>before that event happens. After that, its going to be a race to the finish
>and that could take months or even a year, or more.

From what I've read so far about vaccine production/surge capacity, "or more" is
the applicable phrase.

Also, historically it seems like each wave lasts about 3 months.  That suggests
to me that we'll have the first and maybe second waves with no vaccine
protection whatsoever.
Signature

PeteCresswell

Gary - 04 Jan 2006 03:34 GMT
> Also, historically it seems like each wave lasts about 3 months.  That suggests
> to me that we'll have the first and maybe second waves with no vaccine
> protection whatsoever.

I believe that we need to streamline the process that creates the real
vaccines, not the generic ones. The fruits of the Genome project paying
dividends on the millions invested. But that will be more of a management
problem than a physical one, IMHO.
Jay Stallworth - 04 Jan 2006 03:37 GMT
>> Vaccine manufacturers have been making killed or attenuated vaccines
>> from a
[quoted text clipped - 12 lines]
> a race to the finish and that could take months or even a year, or
> more.

The answers to some simple questions WILL verify your statement that the
disease must break out strongly before it makes any SENSE TO GET A JUMP on
manufacture.

How many antigens (surface and other) are coded in H5N1, how many genes
does it have and how many antigens are involved in human-to-human
transmission?
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.